Latest News and Press Releases

EXTON, PA, April 16, 2024 (GLOBE NEWSWIRE) -- In October of 2023, the US FDA approved Novartis’ intravenous (IV) formulation of Cosentyx (secukinumab) for the treatment of psoriatic arthritis (PsA),...

Dublin, Oct. 12, 2023 (GLOBE NEWSWIRE) -- The "Ankylosing Spondylitis Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global ankylosing spondylitis...

NEWARK, Del, March 31, 2023 (GLOBE NEWSWIRE) -- During the forecast period 2023 to 2033, the Axial Spondyloarthritis management market is expected to grow at a value of 5.1% CAGR, according to...

SEATTLE, Jan. 20, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global ankylosing spondylitis market is estimated to be valued at US$ 4,864.3 million in 2021 and is expected to...

Dublin, June 11, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Axial Spondyloarthritis (axSpA)" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the...

Los Angeles, USA, April 15, 2021 (GLOBE NEWSWIRE) -- New Drugs for Ankylosing Spondylitis Treatment Coming Down the Pipeline: An Updated Clinical Status by DelveInsight  Around 30+ notable...

Dublin, Dec. 21, 2020 (GLOBE NEWSWIRE) -- The "Ankylosing Spondylitis - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. Global Ankylosing Spondylitis...

Dublin, Nov. 04, 2020 (GLOBE NEWSWIRE) -- The "Ankylosing Spondylitis - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. Global Ankylosing Spondylitis...

Ocean View, Delaware, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Autoimmune Disease Diagnostics Market is expected to cross USD 16 billion by 2024; according to a new research report by Global Market...

Ocean View, Delaware, July 13, 2016 (GLOBE NEWSWIRE) -- Autoimmune Disease Diagnostics Market size is estimated to reach USD 15.7 billion by 2023; as per a new research report by Global Market...